Health professionals in priority hospital services in the private and social sector began to be vaccinated against Covid-19 today, announced the Ministry of Health.
On Tuesday, Portugal received the first 8400 doses of vaccines against Covid-19 produced by the American biotechnology company Moderna.
The Minister of Health, Marta Temido, said last Monday that Moderna's vaccines were distributed for the vaccination of «priority health professionals from private and social sector hospitals who collaborate with the National Health Service in treatment and responses to Covid patients'.
“Private groups and social sector entities with agreements with Regional Health Administrations celebrated within the scope of the pandemic received a total of 2370 doses,” says the Ministry of Health in a statement published on the NHS Portal.
Portugal should receive 19.400 doses during the month of January, which will allow to inoculate 9.700 people, since it is a multidose vaccine.
According to the status report made by the Minister of Health, Marta Temido, after a meeting on Monday with the task force of the Covid-19 Vaccination Plan, Portugal has received, to date, 238.950 vaccines from the Pfizer-BioNTech consortium.
More than 75 thousand people were vaccinated, including professionals from the NHS, professionals from the Armed Forces Hospital, the National Institute of Medical Emergency and professionals and residents in residential structures for the elderly and continuing care units.
The vaccination plan against Covid-19 in Portugal began on December 27 in hospitals, covering health professionals, and has already been extended to nursing homes.
The first phase of the plan, until the end of March, also covers professionals from the armed forces, security forces and critical services. At this stage, from February, people aged 50 years and over will also be vaccinated with at least one of the following pathologies: heart failure, coronary heart disease, renal failure or chronic respiratory disease under ventilatory support and/or long-term oxygen therapy duration.
The second phase starts in April and includes people aged 65 years or over and people aged 50 to 64 years, inclusive, with at least one of the following pathologies: diabetes, active malignant neoplasm, chronic kidney disease, failure liver, high blood pressure, obesity and other diseases with lower prevalence that can be defined later, depending on scientific knowledge.
In the third phase, the rest of the population will be vaccinated on a date to be determined. People to be vaccinated throughout the year will be contacted by the National Health Service (SNS).
Comments